SPRB

#3695
Spruce Biosciences, Inc. - Common Stock
60.7 8 USD
+0.03%
Market Price
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
60.78
60.78
Jahresspanne
7.26
240.00
Tagesänderung
+2.96%
Monatliche Änderung
+44.65%
6 month change
+12.85%
Jahresänderung
+452.55%
Vorheriger Schlusskurs
63.3 0
Open
60.7 8
Tief
60.7 8
Hoch
60.7 8
Volumen
5
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Documents

2026

Current report, Q3 FY2026
SPRUCE BIOSCIENCES, INC. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
SPRUCE BIOSCIENCES, INC. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
SPRUCE BIOSCIENCES, INC. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
SPRUCE BIOSCIENCES, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
SPRUCE BIOSCIENCES, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
SPRUCE BIOSCIENCES, INC. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
SPRUCE BIOSCIENCES, INC. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
SPRUCE BIOSCIENCES, INC. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
SPRUCE BIOSCIENCES, INC. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
SPRUCE BIOSCIENCES, INC. current report, Q1 FY2026
8-K

SPRUCE BIOSCIENCES, INC. current report, Q3 FY2021

Full document

Business Context and Reporting Period

Company: Spruce Biosciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 10, 2021
Reporting Period: Second Quarter ended June 30, 2021
Context: The filing announces the issuance of a press release detailing financial results for the quarter ended June 30, 2021, and provides a corporate update. The full text of the press release is included as Exhibit 99.1.

Key Financial Metrics

The provided Form 8-K text serves as a cover document referencing a press release (Exhibit 99.1) but does not contain specific numerical data. Consequently, the following metrics are not available in the source text:

  • Revenue: Not provided in filing text.
  • Profit/Loss: Not provided in filing text.
  • Cash Flow: Not provided in filing text.
  • Margins: Not provided in filing text.
  • Debt and Liquidity: Not provided in filing text.

Material Changes

The filing text does not provide specific comparative data or details regarding material changes versus the prior comparable period. It only confirms that results for the quarter ended June 30, 2021, were announced.

Guidance, Outlook, and Risks

Management Commentary: The filing indicates that a corporate update was provided alongside the financial results, but the specific content of this update is not included in the text of the 8-K itself.
Guidance and Outlook: No specific forward-looking guidance or outlook figures are present in the provided text.
Risks and Contingencies: No specific risks or contingencies are detailed in the provided text.

Investor Verification Checklist

  • Review Exhibit 99.1 (Press Release dated August 10, 2021) for actual revenue, net loss, and cash position figures.
  • Verify the specific details of the "corporate update" mentioned in Item 2.02, as the 8-K text does not elaborate on operational milestones or pipeline updates.
  • Check the Nasdaq Global Select Market listing status for the trading symbol SPRB.
  • Confirm the company's status as an Emerging Growth Company (indicated as checked in the filing) and any associated reporting exemptions.

Nachrichten